Updates
News & Resources
Press Releases
Rokote Laboratories signs an agreement with 3PBIOVIAN for GMP manufacturing of adenovirus vector-based COVID-19 vaccine
Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO
Biovian announces the successful refinancing of its existing debt package and the securing of new funding to support GeneCity facility expansion
Biovian Unveils the Stonemasonry Work of GeneCity Facility
Resources
3PBIOVIAN’s in-house Solution preparation team prepares and provides a wide variety of solutions
Viral safety in viral vector applications – what you need to know?
Support functions at Biovian – warehousing, purchasing, and sterile supply management.
How to select a CDMO for a biopharmaceutical project or program.
Would you like to start a career with a world leading CDMO? We prioritize our employees as the most important asset of our company.
We are a dedicated team of professionals from over 20 countries, working together in a rich, diverse and multicultural environment to deliver tomorrow’s life-transforming therapies.